PMS48 Intravenously Administered Golimumab Significantly Improves Health Related Quality of Life and Work Productivity in Patients with Rheumatoid Arthritis- Results of a Phase III, Placebo-Controlled Trial
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.237
https://www.valueinhealthjournal.com/article/S1098-3015(12)00302-6/fulltext
Title :
PMS48 Intravenously Administered Golimumab Significantly Improves Health Related Quality of Life and Work Productivity in Patients with Rheumatoid Arthritis- Results of a Phase III, Placebo-Controlled Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00302-6&doi=10.1016/j.jval.2012.03.237
First page :
A42
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
1012